← All trials
NCT04763473
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 9, 2021
- Primary completion
- Feb 15, 2022
- Completion date
- Feb 15, 2022
- First posted
- Feb 21, 2021
- Last posted
- Apr 8, 2021
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of AdelaideLead sponsor
- University of AdelaideOverall official - principal investigator
- University of AdelaideReponsible party - principal investigator
- Commonwealth Scientific and Industrial Research Organisation, AustraliaCollaborator
- Isagenix International LLCCollaborator
- Prolongevity TechnologiesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.